BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Total	$ 1,931,497	$ 5,389,089
Research and development services (over-time)
Disaggregation of Revenue [Line Items]
Total	1,128,511	2,975,961
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue [Line Items]
Total	81,947	0
Supply chain
Disaggregation of Revenue [Line Items]
Total	38,577	1,438,106
Asset marking
Disaggregation of Revenue [Line Items]
Total	400,491	587,012
Large scale DNA production
Disaggregation of Revenue [Line Items]
Total	$ 281,971	$ 388,010